Search
for
Sort by
Research 151–180 of 1000+
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- 1H NMR-based lipidomics of rodent fur: species-specific lipid profiles and SCD1 inhibitor-related dermal toxicity
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- A review of Janus kinase inhibitor use in scarring alopecia
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Enzyme Inhibitors from Gorgonians and Soft Corals
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Steroid inhibitors of androgen-potentiated actions on skin
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Tanshinone, a Natural NADPH Oxidase Inhibitor, Mitigates Testosterone-Induced Hair Loss
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Partial Proteasome Inhibitors Induce Hair Follicle Growth by Stabilizing β-Catenin
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure